'I've felt a massive drop.' Vacation-rental owners across the U.S. are seeing bookings coming to a screeching halt—and not because renters have disappeared.
Lilly Lazarus at one of her six vacation rental homes in Houston. Like many short-term rental homeowners, her properties have recently received fewer bookings than usual.Sabrina Must is wondering where her vacation rental bookings have gone.
“I would have made upwards of $12,000 in a month in the summer,” says Ms. Must, 37, who for just over three years has short-term rented her two-bedroom, one-bathroom property in Encinitas, Calif., a beach town located about 25 miles north of San Diego. “Any weekend I wanted to be booked during the pandemic, I was booked. It was kind of like that prepandemic. Not as busy, but still busy.”
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Iguana causes large scale power outage in South Florida cityThe massive, spiky and scaly invasive creatures are known for wreaking havoc across the state.
Baca lebih lajut »
TSX gains as Bank of Canada signals slowdown in rate hikesCanada's main stock index climbed on Wednesday as investors shrugged off potential impact from a oversized rate hike by the Bank of Canada and digested commentary from the central bank hinting at an end to its monetary policy tightening.
Baca lebih lajut »
Speedier drug approvals hit slowdown as FDA faces scrutinyThe Food and Drug Administration is slowing its use of a pathway that expedites the approval of promising drugs. politics fda kprc2 click2houston
Baca lebih lajut »
Speedier drug approvals hit slowdown as FDA faces scrutinyThe Food and Drug Administration is slowing its use of a pathway that expedites the approval of promising drugs
Baca lebih lajut »
Speedier drug approvals hit slowdown as FDA faces scrutinyWASHINGTON (AP) — Expedited drug approvals slowed this year as the Food and Drug Administration's controversial accelerated pathway came under new scrutiny from Congress, government watchdogs and some of the agency’s own leaders.
Baca lebih lajut »
Speedier drug approvals hit slowdown as FDA faces scrutinyThe Food and Drug Administration is slowing its use of a pathway that expedites the approval of promising drugs.
Baca lebih lajut »